BSE filing, NSE: JMFINANCIL. Summary written from the filing by ALFA Finder's alert engine.
JM Financial Ltd: key numbers
- Share price
- ₹108.60
- Market cap
- ₹10,393 Cr
- Revenue (annual)
- ₹4,091 Cr
- Net profit (annual)
- ₹1,202 Cr
- P/E (TTM)
- 10.3×Sector 22.3×
- Promoter holding
- 57.95%+0.92% QoQ
- FII holding
- 16.87%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from JM Financial Ltd
All →JM Financial Earnings Call Transcript: Key Takeaways
Q2 FY27 net revenue ₹712 Cr; H1 revenue +7% to ~₹1,600 Cr, H1 PAT ₹531 Cr. Growth is uneven: private markets is lumpy, deal sizes were cut, and Q2 PAT is not stated.
- Call
- Guides 20% growth
JM Financial Dividend
JM Financial's board declared an interim dividend of Rs 1.65 per equity share for FY 2026-27 on November 4, 2026. The record date is November 11, 2026, with payment proposed by November 20, 2026.
JM Financial Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue Rs 1,056 Cr (+1.1% YoY), PAT Rs 240 Cr (-11.3%); H1 PAT Rs 531 Cr (-26.6%). Loans and wealth AUM grew; profit fell on lower Capital Markets and Treasury earnings.
JM Financial Results Update
JM Financial reported Q2FY27 net revenue of Rs. 712 crore and PAT of Rs. 240 crore, down 11% YoY. It declared an interim dividend of Rs. 1.65.
JM Financial Q2 FY27 Results: Net Profit ₹227.7 Cr, Down 13.1% YoY
JM Financial Ltd reported revenue from operations of ₹1,032 Cr (+0.1% YoY) and net profit of ₹227.7 Cr (-13.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹227.7 Cr · -13.1% YoY
JM Financial Other Announcement
JM Financial filed its quarterly shareholding pattern for the quarter ended 30 September 2025. It is a periodic disclosure with no transaction, money or corporate event.
Other management change announcements
All →Laxmi Organic Industries Management Change
Laxmi Organic appointed Rajesh Naik as Executive Director (Operations) for five years. He brings 34 years of chemical industry experience, including senior BASF leadership.
- Execution
- 60 months
Vaishali Pharma Management Change
Vaishali Pharma appointed Rohil Desai and Ketur Shah as independent directors, subject to shareholder approval. The board deferred a preferential issue proposal without any decision.
Viksit Engineering Management Change
Viksit Engineering's board redesignated director Kushal Chaturvedi as Non-Executive Chairman effective 5 November 2026. The company confirmed he is not debarred from holding directorship.
Welspun Enterprises Management Change
Welspun Enterprises' board accepted the resignations of its CHRO and Company Secretary and appointed Ravi Singh as CHRO and Priya Pakhare as Company Secretary. These are senior management and KMP changes with no financial impact.
Rashi Peripherals Management Change
Rashi Peripherals appointed Sanjeev Keskar as Non-Executive Independent Director and Price Waterhouse Chartered Accountants LLP as Statutory Auditor, both effective 5 November 2026. The filing is a board outcome reporting these management changes.
Kshitij Polyline Management Change
Kshitij Polyline's independent director Ruhini Kumar Chakraborty resigned, citing personal reasons. He also exits the audit, nomination and stakeholders committees.